MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.artd.2026.102134

Медицинская библиотека · Arthroplasty today · 2026

Preoperative Weight Loss Before Total Joint Arthroplasty Using Novel Glucagon-Like Peptide-1 Agonists.

Seward Michael W, Cleary Emmett J, DeNovio Anthony C, Grimm Jessica A, Curry Timothy B, Beam Brian B, Hannon Charles P, Abdel Matthew P

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

This study determined the prevalence of glucagon-like peptide-1 (GLP-1) use before total joint arthroplasty (TJA), measured weight loss of patients on GLP-1s, and evaluated if GLP-1s were associated with outcomes.

METHODS

We identified 6482 patients (2990 hips; 3492 knees) who had primary TJAs between 2019 and February 2023. The mean age was 67 years, 50% were female, and 12% had a body mass index ≥40 kg/m2. Univariable and multivariable models evaluated outcomes. Mean follow-up was 3 years.

RESULTS

The prevalence of GLP-1s before TJA was 3%, increasing from 2% in 2019 to 5% in 2022. The mean preoperative weight change on GLP-1s was -9 pounds (range, -110 to +36 pounds). Among patients taking GLP-1s, 19% lost ≥20 pounds prior to surgery, and the mean body mass index change was -1.4 kg/m2 (range, -16.3 to 6.2 kg/m2). In univariable analyses, GLP-1 use was not associated with revisions (P = .35), reoperations (P = .09), or complications (P = .23). In multivariable analyses, GLP-1s were not associated with revisions (P = .66), reoperations (P = .34), or complications (P = .85). There was no difference in the risk of a 90-day postoperative emergency department visit between those on GLP-1s vs not on those medications (odds ratio, 1.5; P = .07).

CONCLUSIONS

The prevalence of preoperative GLP-1s before TJA increased from 2% in 2019 to 5% in 2022, and preoperative weight change on GLP-1s varied considerably. GLP-1s were not associated with decreased postoperative risks but investigational GLP-1s before TJA require further study.

LEVEL OF EVIDENCE: Level III.

Для цитирования: Seward Michael W, Cleary Emmett J, DeNovio Anthony C, Grimm Jessica A, Curry Timothy B, Beam Brian B, Hannon Charles P, Abdel Matthew P. Preoperative Weight Loss Before Total Joint Arthroplasty Using Novel Glucagon-Like Peptide-1 Agonists.. Arthroplasty today. 2026. DOI: 10.1016/j.artd.2026.102134.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.